Honeywell's second quarter of 2026 marked its debut as pure-play Honeywell Technologies following the June 29 Aerospace spin-off, and the company delivered better-than-expected results that prompted a broad guidance raise. Organic sales grew 4%, led by Building Automation (+9%) and stronger-than-anticipated Industrial Automation (+4%), while Process Automation & Technology dipped 1% on a tough catalyst comparison but still beat plan. Orders were the standout, up 16% organically with double-digit short-cycle demand in every segment and PA&T orders up 24% (book-to-bill above 1.2), lifting backlog 9%. Segment margin expanded 100 basis points to 19% and segment profit rose 9% on productivity, volume leverage, and ahead-of-plan stranded-cost removal, driving adjusted EPS up 10% to $1.95 (up ~20% excluding a $0.16 tax headwind) and free cash flow to roughly $500 million. Management raised full-year organic growth to 3%-4%, segment-margin expansion to 250-290 basis points, and adjusted EPS to $8.20 at the midpoint (up ~27% year-over-year), reaffirming ~$2 billion of free cash flow at ~95% conversion. The quarter also completed the portfolio transformation, with the Quantinuum IPO (47% stake retained), the July 17 close of the Johnson Matthey Catalyst Technologies acquisition (~13x EBITDA), and the imminent close of two Industrial Automation divestitures (removing ~$400 million of 2026 revenue). Strategically, leadership emphasized a sharp second-half PA&T inflection driven by LNG and catalyst, a high-growth-vertical pivot (data centers, hospitality, healthcare, semiconductors) increasingly visible in orders, ~15% Forge software ARR growth, and a resilient, heavily localized Middle East business, framing 2027 as incrementally stronger than at the June Investor Day. On a consolidated GAAP basis (including the legacy Aerospace segment and a one-time gain on the Quantinuum deconsolidation), the company reported net sales of $9.72 billion, an operating margin of 17.9%, and diluted EPS of $17.83.